Abstract 501: Discovery of BPI-460372, a potent and selective inhibitor of TEAD for the treatment of solid tumors harboring Hippo pathway aberrationsHongling Shen, Jiabing Wang, Jinheng Gao et al.|Cancer Research|2023Cited by 11
Abstract 495: Discovery of BPI-221351, a potent, selective, orally available, and brain penetrating dual inhibitor of mutant IDH1/2Hongling Shen, Jia‐Bing Wang, Xiaofeng Xu et al.|Cancer Research|2023Cited by 2